Clinical Trial

Novel On-body Evaluation of Cardiac Health for Oncology

Study acronym: NOECHO
Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
The goal of this study is to develop a wearable sensor system that can estimate left ventricular ejection fraction (LVEF), which is a measurement of the heart's function.
Protocol Amendment History 2 changes
notable Enrollment increased: 50 -> 500 participants 2026-05-21
notable Trial sites expanded: 1 -> 7 locations 2026-05-21
Trial Details
NCT Number NCT07158450
Lead Sponsor Skribe Medical
Collaborators: University of Rochester
Conditions Cardiotoxicity, Heart Failure
Enrollment 500 participants
Start Date 2025-10-09
Primary Completion 2026-09 (estimated)
Study Completion 2026-09 (estimated)
Updated on ClinicalTrials.gov 2026-05-20